Scheme of pharmacotherapy - Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29
|
EN
|
Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29
|
Scheme of pharmacotherapy - Only preoperatively (no standard): 5-FU 250 mg/m2 i.v. continuous infusion on days 1-13 nad 22-35 and oxaliplatin 50mg/m2 i.v. day 1,8,22 and 29
|
Scheme of pharmacotherapy - UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy
|
EN
|
UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy
|
Scheme of pharmacotherapy - UFT (300-340mg/m2/day) and LV (22.5-90 mg/day) po continuously, 5(-7) days per week, together with radiotherapy
|
Scheme of pharmacotherapy - Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation
|
EN
|
Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation
|
Scheme of pharmacotherapy - Capecitabine 800-825 mg/m2 bid po, day 1-5, together with radiation or continuously untill end of radiation
|
Scheme of pharmacotherapy - 5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5
|
EN
|
5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5
|
Scheme of pharmacotherapy - 5-FU 1000 mg/m2 i.v. continuous infusion, day 1-5, weeks 1 and 5
|
Scheme of pharmacotherapy - 5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week
|
EN
|
5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week
|
Scheme of pharmacotherapy - 5-FU 225 mg/m2 i.v. continuous infusion, 5 days per week
|
Scheme of pharmacotherapy - 5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22
|
EN
|
5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22
|
Scheme of pharmacotherapy - 5-FU 400 mg/m2 + 100 mg i.v. bolus, d 1,2, 11,12,21,22
|
Scheme of pharmacotherapy - 5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5
|
EN
|
5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5
|
Scheme of pharmacotherapy - 5-FU 325-350 mg/m2 + LV 20 mg/m2i.v. bolus, day1-5, weeks 1 and 5
|
Other
|
EN
|
Other
|
A scheme of pharmacotherapy which is not mentioned elsewhere on this list
|